tiprankstipranks
Trending News
More News >
Rohto Pharmaceutical Co Ltd (JP:4527)
:4527
Japanese Market

Rohto Pharmaceutical Co (4527) Financial Statements

Compare
1 Followers

Rohto Pharmaceutical Co Financial Overview

Rohto Pharmaceutical Co's market cap is currently $474.07B. The company's EPS TTM is ¥27.38; its P/E ratio is 15.00; and it has a dividend yield of 1.96%. Rohto Pharmaceutical Co is scheduled to report earnings on May 13, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue¥ 308.63B¥ 270.84B¥ 238.66B¥ 199.65B¥ 181.05B
Gross Profit¥ 169.38B¥ 157.29B¥ 137.42B¥ 116.49B¥ 106.73B
Operating Income¥ 38.47B¥ 40.05B¥ 33.96B¥ 29.35B¥ 22.99B
EBITDA¥ 56.42B¥ 50.40B¥ 41.34B¥ 35.81B¥ 28.61B
Net Income¥ 31.00B¥ 30.94B¥ 26.38B¥ 21.13B¥ 16.74B
Balance Sheet
Cash & Short-Term Investments¥ 77.16B¥ 89.21B¥ 79.95B¥ 72.79B¥ 52.96B
Total Assets¥ 421.88B¥ 346.18B¥ 309.68B¥ 274.63B¥ 225.79B
Total Debt¥ 50.22B¥ 10.49B¥ 11.69B¥ 21.38B¥ 8.10B
Net Debt¥ -26.94B¥ -78.72B¥ -68.26B¥ -51.41B¥ -44.87B
Total Liabilities¥ 150.43B¥ 99.14B¥ 94.60B¥ 90.80B¥ 69.18B
Stockholders' Equity¥ 260.10B¥ 246.32B¥ 209.57B¥ 178.28B¥ 155.91B
Cash Flow
Free Cash Flow¥ 27.84B¥ 25.33B¥ 21.02B¥ 15.92B¥ 9.70B
Operating Cash Flow¥ 36.92B¥ 34.24B¥ 30.92B¥ 27.25B¥ 20.01B
Investing Cash Flow¥ -57.55B¥ -16.32B¥ -13.18B¥ -16.41B¥ -10.24B
Financing Cash Flow¥ 3.70B¥ -13.78B¥ -16.20B¥ 3.47B¥ -2.35B
Currency in JPY

Rohto Pharmaceutical Co Earnings and Revenue History

Rohto Pharmaceutical Co Debt to Assets

Rohto Pharmaceutical Co Cash Flow

Rohto Pharmaceutical Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis